Anuh Pharma

{
  "main_header": {
    "sid": 905552,
    "name": "Anuh Pharma",
    "stock_name": "Anuh Pharma",
    "full_name": "Anuh Pharma Ltd",
    "name_url": "stocks-analysis/anuh-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "82.74",
    "chg": -2.69,
    "chgp": "-3.15%",
    "dir": -1,
    "prev_price": "85.43",
    "mcapval": "847.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 506260,
    "symbol": "ANUHPHR",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE489G01022",
    "curr_date": "May 06",
    "curr_time": "",
    "bse_nse_vol": "1.03 lacs",
    "exc_status": "Active",
    "traded_date": "May 06, 2026",
    "traded_date_str": "2026 05 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/anuh-pharma-905552-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Anuh Pharma Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anuh-pharma-ltd-is-rated-sell-by-marketsmojo-3973226",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AnuhPharmaLtd_mojoScore_3973226.png",
        "date": "2026-05-04 10:10:17",
        "description": "Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 May 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Anuh Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anuh-pharma-ltd-is-rated-sell-3959044",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AnuhPharmaLtd_mojoScore_3959044.png",
        "date": "2026-04-23 10:10:22",
        "description": "Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 23 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Anuh Pharma Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anuh-pharma-ltd-is-rated-sell-by-marketsmojo-3943469",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AnuhPharmaLtd_mojoScore_3943469.png",
        "date": "2026-04-12 10:10:12",
        "description": "Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Anuh Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anuh-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-3936429",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AnuhPharmaLtd_technicaldot_3936429.png",
        "date": "2026-04-08 08:03:01",
        "description": "Anuh Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish trend. Despite a modest day gain of 1.07%, the stock’s technical indicators present a complex picture, with some weekly signals turning mildly bullish while monthly trends remain cautious. This analysis delves into the recent technical parameter changes, evaluating key momentum indicators such as MACD, RSI, moving averages, and others to provide a comprehensive view of the stock’s near-term outlook."
      },
      {
        "title": "Anuh Pharma Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anuh-pharma-ltd-is-rated-sell-by-marketsmojo-3928257",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AnuhPharmaLtd_mojoScore_3928257.png",
        "date": "2026-04-01 10:10:31",
        "description": "Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, a rating that was last updated on 04 February 2026. While this rating change occurred in early February, the analysis and financial metrics presented here reflect the stock's current position as of 01 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Anuh Pharma Ltd Falls to 52-Week Low of Rs 66.83 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anuh-pharma-ltd-stock-falls-to-52-week-low-of-rs6683-3924585",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AnuhPharmaLtd_priceRelatedfactors_3924585.png",
        "date": "2026-03-30 11:54:11",
        "description": "For the third consecutive session, Anuh Pharma Ltd has declined, culminating in a fresh 52-week low of Rs 66.83 on 30 Mar 2026. This latest drop extends the stock’s downward trend, with a cumulative loss of 5.3% over the past three days, underperforming its sector by nearly 3% today alone."
      },
      {
        "title": "Anuh Pharma Ltd Technical Momentum Shifts Amid Bearish Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anuh-pharma-ltd-technical-momentum-shifts-amid-bearish-sentiment-3909207",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AnuhPharmaLtd_technicaldot_3909207.png",
        "date": "2026-03-24 08:04:01",
        "description": "Anuh Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a bearish trend. Despite some mildly bullish signals on weekly MACD and KST indicators, the overall technical landscape remains subdued, reflecting the stock’s recent price decline and challenging market conditions."
      },
      {
        "title": "Anuh Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anuh-pharma-ltd-is-rated-sell-3904975",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AnuhPharmaLtd_mojoScore_3904975.png",
        "date": "2026-03-21 10:10:13",
        "description": "Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Anuh Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anuh-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3902304",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AnuhPharmaLtd_technicaldot_3902304.png",
        "date": "2026-03-20 08:03:08",
        "description": "Anuh Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish trend. Despite a recent downgrade in its Mojo Grade to Sell from Strong Sell, the stock’s technical indicators present a complex picture, with some signals suggesting cautious optimism while others reinforce bearish pressures."
      }
    ],
    "total": 5150,
    "sid": "905552",
    "stock_news_url": "https://www.marketsmojo.com/news/anuh-pharma-905552"
  },
  "announcements": [
    {
      "caption": "Announcement Under Regulation 30 (LODR) - Updates",
      "datetime": "04-May-2026",
      "details": "Approval from World Health Organization (WHO) Prequalification (WHO PQ) for Amodiaquine Hydrochloride USP",
      "source": "BSE"
    },
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "30-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Anuh Pharma Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24230MH1960PLC011586</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NIL</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Manan Jayesh Vadhan <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: aplcs@sk1932.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Darshan Dhirajllal Rampariya <br/> Designation: Chief Financial Officer <br/> EmailId: darshan.r@anuhpharma.com</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "28-Apr-2026",
      "details": "Newspaper Publication for Second 100 Days Campaign - Saksham Niveshak.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Anuh Pharma Ltd has declared <strong>30%</strong> dividend, ex-date: 14 Aug 25",
          "dt": "2025-08-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Anuh Pharma Ltd has announced <strong>5:10</strong> stock split, ex-date: 31 Jul 06",
          "dt": "2006-07-31",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Anuh Pharma Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 15 Jul 25",
          "dt": "2025-07-15",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Anuh Pharma Ltd is Rated Sell by MarketsMOJO

2026-05-04 10:10:17

Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Anuh Pharma Ltd is Rated Sell

2026-04-23 10:10:22

Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 23 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Anuh Pharma Ltd is Rated Sell by MarketsMOJO

2026-04-12 10:10:12

Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Anuh Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-04-08 08:03:01

Anuh Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish trend. Despite a modest day gain of 1.07%, the stock’s technical indicators present a complex picture, with some weekly signals turning mildly bullish while monthly trends remain cautious. This analysis delves into the recent technical parameter changes, evaluating key momentum indicators such as MACD, RSI, moving averages, and others to provide a comprehensive view of the stock’s near-term outlook.

Read full news article

Anuh Pharma Ltd is Rated Sell by MarketsMOJO

2026-04-01 10:10:31

Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, a rating that was last updated on 04 February 2026. While this rating change occurred in early February, the analysis and financial metrics presented here reflect the stock's current position as of 01 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Anuh Pharma Ltd Falls to 52-Week Low of Rs 66.83 as Sell-Off Deepens

2026-03-30 11:54:11

For the third consecutive session, Anuh Pharma Ltd has declined, culminating in a fresh 52-week low of Rs 66.83 on 30 Mar 2026. This latest drop extends the stock’s downward trend, with a cumulative loss of 5.3% over the past three days, underperforming its sector by nearly 3% today alone.

Read full news article

Anuh Pharma Ltd Technical Momentum Shifts Amid Bearish Sentiment

2026-03-24 08:04:01

Anuh Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a bearish trend. Despite some mildly bullish signals on weekly MACD and KST indicators, the overall technical landscape remains subdued, reflecting the stock’s recent price decline and challenging market conditions.

Read full news article

Anuh Pharma Ltd is Rated Sell

2026-03-21 10:10:13

Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Anuh Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-03-20 08:03:08

Anuh Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish trend. Despite a recent downgrade in its Mojo Grade to Sell from Strong Sell, the stock’s technical indicators present a complex picture, with some signals suggesting cautious optimism while others reinforce bearish pressures.

Read full news article

View All News